Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion type Assertion NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_head.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion description "[Other BRCA-associated cancers have been shown to have greater sensitivity to platinum and poly(ADP-ribose) polymerase (PARP) inhibitors with better clinical outcomes than in sporadic cases; however, outcomes in BRCA-associated PAC have not been reported.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_provenance.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion evidence source_evidence_literature NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_provenance.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion SIO_000772 21934105 NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_provenance.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion wasDerivedFrom befree-20140225 NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_provenance.
- NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_assertion wasGeneratedBy ECO_0000203 NP590224.RAdY5VM0Y0cBRpIzAD8hshlmtxVGhoJ2-9ly2Cjw1ET6Q130_provenance.